Literature DB >> 2654011

Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes.

E J Goetzl1, K T Kodama, C W Turck, S A Schiogolev, S P Sreedharan.   

Abstract

Human cultured T lymphocytes of the Jurkat line and myeloma cells of the U266 line cleaved the 28 amino acid vasoactive intestinal peptide (VIP1-28) preferentially at three sites with time- and temperature-dependence. The fragments VIP4-28 and VIP23-28) from an endopeptidase activity, and VIP15-28 from a trypsin-like peptidase, together represented a range of 26-65% of the VIP1-28 recovered after 2 hr at 37 degrees C or 4 hr at 22 degrees C, based on the absorbance of purified peptides and the radioactivity of [125I]Tyr10 VIP1-28. The endopeptidase activity was associated with membranes recovered after disruption of U266 cells by nitrogen cavitation. Pretreatment of intact U266 and Jurkat cells with diisopropylfluorophosphate (DFP) and the subsequently isolated subcellular particles with phenylmethylsulphonylfluoride (PMSF) and leupeptin inhibited the trypsin-like enzyme by a mean of 80%, without suppressing endopeptidase activity. In contrast, 0.1 mM DL-thiorphan and phosphoramidon blocked selectively a range of 35-70% of the endopeptidase activity in membrane preparations and intact cells. The capacity of lymphocytes to degrade VIP1-28 may substantially alter the effects of this neuromediator on functions of some subsets of T and B cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654011      PMCID: PMC1385156     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Identification and sequencing of cDNA clones encoding the granule-associated serine proteases granzymes D, E, and F of cytolytic T lymphocytes.

Authors:  D Jenne; C Rey; J A Haefliger; B Y Qiao; P Groscurth; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

2.  Vasoactive intestinal peptide and neuropeptide modulation of the immune response.

Authors:  M S O'Dorisio; C L Wood; T M O'Dorisio
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

3.  Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.

Authors:  C A Ottaway; G R Greenberg
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

4.  Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.

Authors:  C L Wood; M S O'Dorisio
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

5.  Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).

Authors:  M S O'Dorisio; C L Wood; G D Wenger; L M Vassalo
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

6.  Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man.

Authors:  J M Lundberg; J Fahrenkrug; T Hökfelt; C R Martling; O Larsson; K Tatemoto; A Anggård
Journal:  Peptides       Date:  1984 May-Jun       Impact factor: 3.750

7.  Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons.

Authors:  L I Larsson; J Fahrenkrug; O Schaffalitzky De Muckadell; F Sundler; R Håkanson; J R Rehfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

8.  A novel serine esterase expressed by cytotoxic T lymphocytes.

Authors:  M S Pasternack; H N Eisen
Journal:  Nature       Date:  1985 Apr 25-May 1       Impact factor: 49.962

9.  Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.

Authors:  M Altstein; E Bachar; Z Vogel; S Blumberg
Journal:  Eur J Pharmacol       Date:  1983-08-05       Impact factor: 4.432

10.  Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes.

Authors:  A Danek; M S O'Dorisio; T M O'Dorisio; J M George
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

View more
  4 in total

1.  Cloning and expression of the human vasoactive intestinal peptide receptor.

Authors:  S P Sreedharan; A Robichon; K E Peterson; E J Goetzl
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.

Authors:  Jian-Ming Li; Christopher T Petersen; Jing-Xia Li; Reema Panjwani; Daniel J Chandra; Cynthia R Giver; Bruce R Blazar; Edmund K Waller
Journal:  Cancer Res       Date:  2016-09-26       Impact factor: 12.701

3.  The SKW 6.4 line of human B lymphocytes specifically binds and responds to vasoactive intestinal peptide.

Authors:  P P Cheng; S P Sreedharan; J L Kishiyama; E J Goetzl
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

4.  Distinct cellular functions mediated by haemopoietic cell-surface proteases.

Authors:  B Bauvois; A Laouar
Journal:  Adv Neuroimmunol       Date:  2007-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.